Unknown

Dataset Information

0

MYB/AKT3 axis is a key driver of ovarian cancer growth, aggressiveness, and chemoresistance

ABSTRACT:

SUBMITTER: Vikramdeo K 

PROVIDER: S-EPMC12337402 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer.
| S-EPMC12522256 | biostudies-literature
Unknown The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness.
| S-EPMC10801894 | biostudies-literature
Unknown Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.
| S-EPMC3189303 | biostudies-literature
Unknown Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness.
| S-EPMC11864563 | biostudies-literature
Unknown Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC).
| S-EPMC8909529 | biostudies-literature
Unknown HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer.
| S-EPMC4148105 | biostudies-literature
Transcriptomics Transcriptomic Profiling Identifies GPNMB as a Key Driver of Gastric Cancer Aggressiveness
2026-05-17 | GSE330529 | GEO
Unknown Glutamine metabolism drives tumor aggressiveness but not chemoresistance in ovarian carcinoma cell lines.
| S-EPMC12776192 | biostudies-literature
Unknown MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness.
| S-EPMC8589861 | biostudies-literature
Unknown PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
| S-EPMC10633943 | biostudies-literature